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Among  myeloid  immune  receptors,  C-type  lectin  receptors  (CLRs)  have  a remarkable  capacity  to  sense
a  variety  of  self  and  non-self  ligands.  The  coupling  of CLRs  to  different  signal  transduction  modules
is  inﬂuenced  not  only  by the receptor,  but  also  by the  nature,  density  and  architecture  of  the ligand,
which  can  affect  the  rate of  receptor  internalization  and  trafﬁcking  to diverse  intracellular  compartments.
Understanding  how  the variety  of  self  and  non-self  ligands  triggers  differential  CLR  signalling  and  function
presents  a fascinating  biological  challenge.  Non-self  ligands  usually  promote  inﬂammation  and  immunity,nnate immunity
-type lectin receptors
yeloid cells
whereas  self  ligands  are  frequently  involved  in communication  and  tolerance.  But pathogens  can  mimic
self-inhibitory  signals  to escape  immune  surveillance,  and  endogenous  ligands  can  contribute  to  the
sensing  of pathogens  through  CLRs.  In  this  review,  we  survey  the complexity  and ﬂexibility  in  functional
outcome  found  in the myeloid  CLRs,  which  is  not  only  based on their  differing  intracellular  motifs,  but is
also  conditioned  by the  physical  nature,  afﬁnity  and avidity  of  the  ligand.
©  2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ntroduction: the C-type lectin domain is a ﬂexible module
or endogenous and exogenous ligands
The C-type lectin-like domain (CTLD) (Drickamer, 1999) is a
tructural motif composed of two loops with conserved cysteines
hat stabilize the structure with intrachain disulphide bridges. The
TLD was initially deﬁned functionally by its ability to bind carbo-
ydrates in a calcium-dependent manner; however, the conserved
tructural module is also capable of calcium-dependent binding
f glycans, lipids and proteins (Zelensky and Gready, 2005). This
eview focuses on integral membrane CLRs expressed on myeloid
ells that modulate functional outcomes (Sancho and Reis e Sousa,
012) (Table 1).
CLRs are frequently promiscuous receptors that can bind more
han one ligand. Myeloid CLRs can act as receptors for endoge-
ous (self) or exogenous (non-self) ligands. Endogenous ligands can
e further subdivided into self ligands involved in cell adhesion
nd communication and those regulating immune homeostasis
García-Vallejo and van Kooyk, 2009) or alternatively can be
eﬁned as “altered-self” neoglycans expressed by transformed cells
van Vliet et al., 2008) or “damaged self” danger signals released or
xposed upon cell death (Sancho and Reis e Sousa, 2013).
The CLR DC-SIGN (CD209) illustrates the diversity of self and
on-self ligands. DC-SIGN binds high mannose and fucose-based
igands (LeX, LeY, LeA, LeB) that can be exposed on a variety of self
eceptors, such as ICAM-2, ICAM-3, CEACAM-1, Mac1 and CEA, or
n non-self proteins such as Salp15 in the saliva of Ixodes,  Arah1
n Schistosoma egg antigen, or structures in pathogens including
iruses, bacteria, fungi and eukaryotic parasites (Geijtenbeek et al.,
000, 2003; Gringhuis et al., 2009b; Hovius et al., 2008). The CLR
incle (CLEC4E) can also bind non-self glycolipids in the cell wall
f bacteria and fungi, while detecting self-damage by recognizing
AP-130 exposed and released by necrotic cells (Ishikawa et al.,
009; Schoenen et al., 2010; Wells et al., 2008; Yamasaki et al.,
009) (Ishikawa et al., 2013). Other CLRs detect one ligand that can
e expressed in a variety of organisms, as described for Dectin-
 (CLEC7A), which detects -1, 3 glucans in a variety of bacteria
nd fungi (Brown, 2006). Some CLRs appear to be restricted to
ndogenous ligands; for example, DNGR-1 (CLEC9A) detects ﬁla-
entous F-actin exposed upon necrosis (Ahrens et al., 2012; Sancho
t al., 2009; Zhang et al., 2012) and Clec12a senses uric acid crystals
ormed during cell death (Neumann et al., 2014).
The spectrum of CLR ligands and the structures bearing them is
ontinually expanding and the general view is that most CLRs are
daptable structures that can bind both endogenous and exogenous
igands, resulting in distinct functional outcomes. The diversity of
ignalling pathways that can be triggered through CLRs depends
nitially on the cytoplasmic signalling motif, and we  proposed a
unctional classiﬁcation of signalling CLRs based on these motifs
ather than the structure of the CTLD (Sancho and Reis e Sousa,
012). However, a single receptor can also signal differentially
epending on the nature of the ligand; whether the ligand is of
ow or high afﬁnity, soluble or particulate, or even its particle size
ill determine the strength and duration of signalling and the
unctional response. Ligand recognition and signal transduction
hrough the CLR have a major impact on how self and non-self struc-
ures modulate myeloid cell function because CLRs work in concert
ith other innate receptors to control immunity and homeostasis.
n this review we examine how the nature of the CLR motif and the
ound ligand inﬂuence differential signal transduction.
o myeloid CLRs transduce an activating or inhibitory
ignal?
Signalling myeloid CLRs can potentially trigger activating or
nhibitory signals, depending on their cytoplasmic signalling motifslogy 220 (2015) 175–184
(Sancho and Reis e Sousa, 2012). Some myeloid CLRs bear a hemI-
TAM structure in their cytoplasmic domain, with a single tyrosine
within an YXXL motif that couples to Syk (Rogers et al., 2005).
Dectin-1, CLEC-2, DNGR-1 and SIGN-R3 belong to this group (Fuller
et al., 2007; Huysamen et al., 2008; Rogers et al., 2005; Sancho
et al., 2009; Tanne et al., 2009). Dectin-1 behaves as an activat-
ing CLR that promotes inﬂammation and immunity in response to
pathogens such as Candida. CLEC-2 behaves as an activating recep-
tor in platelets (Fuller et al., 2007) and myeloid cells (Mourao-Sa
et al., 2011). SIGN-R3 couples to Syk and signals as an activating
receptor (Tanne et al., 2009).
Despite sharing a common hemITAM motif, not all of these
CLRs trigger the same transcriptional programme; for example,
they might be non-activating in some instances and depending on
the context can even trigger inhibitory signals. In a macrophage
cell line exposed to zymosan, a chimeric receptor consisting of the
extracellular Dectin-1 and intracellular CLEC-2 structures induced
Syk-dependent TNF production but not ROS (Kerrigan et al., 2009).
SIGN-R3 can modulate signals by other CLRs (Lefèvre et al., 2013).
In another study, the intracellular DNGR-1 structure was unable to
mediate production of proinﬂammatory cytokines via the extracel-
lular Dectin-1 domain by dendritic cells (DCs) (Zelenay et al., 2012).
The inability of DNGR-1 to act as a myeloid activating receptor is
strongly dependent on the presence of an isoleucine at position-
1 relative to the tyrosine of the YXXL motif, and mutation of this
isoleucine to glycine in the Dectin-1 – DNGR-1 chimera results in
increased cytokine production (Zelenay et al., 2012). The function
of the hemITAM is deﬁned by its binding to Syk, but the afﬁnity for
this binding can be regulated by the particular environment of the
YXXL motif. In this regard, the DEDG motif that precedes the YXXL
sequence in both Dectin-1 and CLEC-2 might be associated with
enhanced association and signalling via Syk (Fuller et al., 2007).
Thus not only the presence of the hemITAM but also the particular
amino-acid environment around the tyrosine appear to inﬂuence
the binding of Syk and the subsequent triggering of activating sig-
nals downstream of hemITAM-coupled CLRs.
A second group of myeloid CLRs couples to ITAM-bearing
domains. MDL-1 (CLEC5A) couples to DAP-12 or DAP-10, which
bear ITAM and YINM motifs, respectively (Bakker et al., 1999; Chen
et al., 2008; Inui et al., 2009). BDCA-2, DCAR, Mincle and Dectin-2
couple to the FcR chain, which bears an ITAM motif that recruits
Syk and mediates CARD9-dependent activation of NF-B (Sancho
and Reis e Sousa, 2012). MCL  couples to FcR (Miyake et al., 2013),
an association that might be mediated by heterodimerization with
Mincle (Lobato-Pascual et al., 2013). Although these receptors are
considered to be activating, Syk recruitment to ITAM domains can
also result in negative signals and inhibition of heterologous recep-
tors. High avidity ligation of ITAM-coupled FcRs in macrophages
triggers a Syk-mediated induction of signalling inhibitors that abro-
gates TLR responses (Wang et al., 2010). Syk can also inhibit TLR
signalling by inducing tyrosine phosphorylation of MyD88 and
TRIF, leading to degradation of these adaptor molecules by the ubi-
quitin ligase Cbl-b (Han et al., 2010). Moreover, Mincle was  recently
shown to interfere with signalling via Dectin-1 despite both recep-
tors signalling via Syk (Wevers et al., 2014), as we  describe
below.
Other myeloid CLRs contain ITIM motifs that recruit phos-
phatases that mediate negative regulation of kinase-associated
heterologous receptors, for example the Syk-coupled CLRs. Co-
ligation of these receptors with activating receptors results in
modulation of the response, and these CLRs are thus candidate
pathogen targets for immune escape. Myeloid CLRs included in this
group are hDCIR, mDcir1 (DCIR), mDcir2, Clec12a (MICL, DCAL-
2, KLRL1, CLL1), MAgH, and Ly49Q (Sancho and Reis e Sousa,
2012). Finally, members of another class of myeloid CLRs do
not bear evident ITAM or ITIM domains; these CLRs include MR,
S. Iborra, D. Sancho / Immunobiology 220 (2015) 175–184 177
Table  1
Mouse and human myeloid CLRs surveyed in this review.
Common name(s) Gene name Signalling
motifs
Early signalling
effectors
Ligand
speciﬁcity
Ligand origin
DC-SIGN, CLEC4L (Hs) CD209 (Hs) YxxL
LL
EEE
ManLAM: LSP1,
KSR1, CNK
RAF-1
Salp15:
MEK-RAF-1
Fucose: LSP1
High mannose
and fucose
(LeX , LeY , LeA ,
LeB)
- HIV-1, measles, Dengue, SARS, CMV,
ﬁloviruses
-  Mycobacterium spp., Lactobacilli spp.,
H.  pylori, E. coli
- C. albicans
- Leishmania spp.
- Ixodes saliva Salp15, Schistosoma egg
antigen, Arah1
- ICAM-2, ICAM-3, CEACAM-1, Mac1,
CEA
SIGNR3  (Mm)  Cd209d (Mm)  YxxI HemITAM-SYK High mannose
and fucose
- M.  tuberculosis
BDCA-2, DLEC, CD303, CLECSF7 (Hs) CLEC4C (Hs) Tmb K
EEE
FcR chain-
ITAM-SYK
gp120 HIV-1
DCAR (Mm)  Clec4b1 (Mm)  Tmb  R FcR chain-
ITAM-SYK
ND ND
mDCAR1 (Mm) Clec4b2 (Mm)  Tmb  R FcR chain-
ITAM-SYK?
ND ND
DCIR, CLECS-F6, LLIR (Hs) CLEC4A (Hs) IxYxxV SHP-1, SHP-2 ND HIV-1
DCIR, Dcir1, Clecf6 (Mm)  Clec4a2 (Mm)  IxYxxV SHP-1, SHP-2 Syalilated
glicoproteins
- Syalilated intravenous
inmunoglobulins
Dcir2 (33D1) (Mm) Clec4a4 (Mm) IxYxxV ND ND ND
Dectin-2 CLEC6A (Hs)
Clec4n (Mm)
Tmb  R FcR chain-
ITAM-SYK
Src kinases
CARD9
High mannose
-mannans
- M.  tuberculosis
- A. fumigatus,  C. albicans, S. cerevisiae,
P.  brasiliensis, H.  capsulatum, M.
audouinii, T. rubrum, C. neoformans
- House dust mite allergens, S. mansoni
eggs extracts
- Ligand on CD4+ CD25+ T cells
MCL,  CLECS-F8 CLEC4D (Hs)
Clec4d (Mm)
ND FcR chain
through
Mincle
heterodimer
Glycolipids -M.  tuberculosis
Mincle CLEC4E (Hs)
Clec4e (Mm)
Tmb  R FcR chain-
ITAM-SYK
Src kinases
CARD9
Glycolipids,
SAP-130.
-M. tuberculosis
- C. albicans, Malassezia spp, Fonsecaea
pedrosoi.
- Dead cells
MDL-1,  CLECSF5 CLEC5A (Hs)
Clec5a (Mm)
Tmb  K DAP10 – PI3K
DAP12-ITAM-
SYK
ND - Dengue virus
- Role in osteoclastogenesis:
endogenous ligand?
CLEC12A, MICL, DCAL-2, KLRL1, CLL1 CLEC12A (Hs)
Clec12a (Mm)
VxYxxL SHP-1, SHP-2 Monosodium
urate crystals
- Dead cells.
CLEC-2  CLEC1B (Hs)
Clec1b (Mm)
YxxL
DEDG
LL
HemITAM-
SYK;
Src and Tec
kinases.
- Podoplanin
-  Rhodocytin
- Lymphatic endothelial cells, lymph
node stroma, tumor cells, HIV-1
-  Snake venom
DNGR-1, CLEC9A CLEC9A (Hs)
Clec9a (Mm)
YxxL HemITAM-SYK F-actin - Dead cells
Dectin-1, -GR, CLECSF12 CLEC7A (Hs)
Clec7a (Mm)
YxxL
DEDG
HemITAM-SYK
CARD9
RAF-1
-1,3 glucans - Mycobacteria spp.
- P. carinii,  C. albicans, A. fumigatus,
Penicillium marneffei, Coccidioides
posadasii,  and Histoplasma capsulatum
- Ligand on T cells
MR,  MMR,  CD206 MRC1 (Hs)
Mrc1 (Mm)
FxxxxY
LL
CDC42, RHOB,
PAKs, ROCK1
High mannose,
fucose, sLeX,
GlcNAc
- HIV-1, Dengue
- M.  tuberculosis, M.  kansasii, F.
tularensis, K. pneumoniae, S.
pneumoniae
-  P. carinii,  C. albicans, C. neoformans
- Leishmania spp.
D
a
i
r
t
m
t
tEC-205, DC-SIGN, SIGNR1, Langerin, MGL, CLEC-1, DCAL-1, LOX-1
nd LSECtin. DC-SIGN is the archetypal receptor of this group and
ts triggering results in modulation of signalling by heterologous
eceptors (Sancho and Reis e Sousa, 2012).
An additional source of complexity in signal transduction
hrough myeloid CLRs is their capacity to form dimers or multi-
ers. Modelling of CLEC-2 signalling through hemITAMs indicates
hat Syk binding requires phosphorylation of paired YXXL motif
yrosines in a homodimer. Stoichiometric analyses show that- Glycosylated allergens
- Lysosomal hydrolases, thyroglobulin,
l-selectin, MUC-1, apoptotic cells
CLEC-2 pre-exists as a dimer which then aggregates after ligand
binding (Hughes et al., 2010; Watson et al., 2009). Some CLRs can
also heterodimerize; for example, MCL  forms a functional het-
eromeric complex with Mincle and FcR (Lobato-Pascual et al.,
2013). Through this interaction, MCL  acquires signalling capacity
via FcR, whereas Mincle beneﬁts from the endocytic capacity of
MCL. Formation of the heterodimer could also potentially increase
ligand binding afﬁnity or expand ligand speciﬁcity (Yamasaki,
2013).
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he nature of the ligand can modulate signals through
yeloid CLRs
In addition to the signalling motifs borne by the CLRs, signalling
an also be inﬂuenced by the nature of the ligand, which can alter
eceptor engagement or induce conformational changes. CLRs fre-
uently bind more than one ligand, each with a distinct afﬁnity and
vidity for the receptor. The importance of the nature of the ligand
s well illustrated by signalling through DC-SIGN. Following binding
f mannosylated lipoarabinomannan from Mycobacterium tubercu-
osis, DC-SIGN couples to a LSP1 – KSR1 – CNK signalosome, leading
o activation of Raf-1 and acetylation of the NF-B p65 subunit,
hich results in enhanced proinﬂammatory responses (Gringhuis
t al., 2009a). High mannose ligands from Candida or HIV-1 behave
imilarly and induce Raf-1 activation, whereas fucose-based lig-
nds cause dissociation of the LSP1-based signalosome, so that
C-SIGN associates only with LSP1 and proinﬂammatory responses
re suppressed (Gringhuis et al., 2009a). Salp15, a protein produced
y the salivary glands of Ixodes scapularis ticks, also binds DC-SIGN
o promote Raf-1 activation, in this case leading to MEK activation
nd suppression of inﬂammation (Hovius et al., 2008).
Ligand afﬁnity and avidity can affect the quantity and dura-
ion of signals through the ITAM domain, resulting in differential
esponses (Hamerman et al., 2009; Yamasaki et al., 2004) (Fig. 1A).
he FcR chain contains a consensus ITAM with two tyrosines that
pon binding of a high avidity ligand becomes fully phosphorylated
nd associates with the kinase Syk triggering an activating sig-
al that contributes to immunity and inﬂammation (Mócsai et al.,
010). However, when ITAM-coupled receptors associate with low
fﬁnity or avidity ligands, the ITAM domain is hypophosphorylated
nd this results in preferential association with SH2-containing
hosphatases, a conﬁguration termed inhibitory ITAM (Blank et al.,
009). The paradigm of the differential effect of low afﬁnity and
vidity is the FcRI receptor, which associates with the FcR
hain for signalling. Upon interaction with IgA monomers, the cou-
led FcR chain is partially phosphorylated and recruits SHP-1
hosphatase, being able to inhibit signals through heterologous
eceptors (Pasquier et al., 2005). Some CLRs that couple to the FcR
hain, including Mincle, Dectin-2, BDCA-2, DCAR or MCL, could thus
otentially act in a similar manner to the FcRI receptor and trig-
er phosphatase signalling upon binding to a low afﬁnity/avidity
igand, which would lead to inhibition of signals triggered through
eterologous receptors that could themselves be CLRs signalling
ia Syk. In this way, ITAM-associated CLRs could respond to low
alency ligation by soluble extracellular ligands that would induce
road suppression and dampening of inﬂammation and immunity.
his recognition of low afﬁnity/avidity ligands by ITAM-coupled
eceptors would thus act similarly to ITIM-coupled CLRs, which
rigger a negative signal upon co-ligation with heterologous recep-
ors by multivalent ligands, selectively regulating the co-ligated
eceptor (Hamerman et al., 2009).
Afﬁnity is also inﬂuenced by whether the ligand exists in a
onomeric or oligomeric state, which affects how the ligand is pre-
ented to the CLR (Fig. 1B). Soluble ligands for CLRs are poor triggers
f activating signalling, whereas the same ligands in plated form
romote Syk signalling effectively. This might provide a mechanism
o restrict activation of the tightly regulated processes of phagocy-
osis and ROS production to situations when the host is in direct
ontact with pathogen. In this regard, Dectin-1 has been proposed
o cluster in a “phagocytic synapse” only when it interacts directly
ith particulate, but not soluble, -glucans (Goodridge et al., 2011).
D45 and CD148 phosphatases are initially needed for dephos-
horylation of the Src family kinase Lyn at its inhibitory tyrosine
Y507), but are subsequently excluded from the -glucan particle
ontact site to permit Syk association and signalling (Goodridge
t al., 2011). This formation of a phagocytic synapse that excludeslogy 220 (2015) 175–184
membrane phosphatases may be a general feature of other phago-
cytic CLRs, which would thus discriminate between detection of
soluble and particulate ligands (Fig. 1C). After detection of soluble
ligands, the inhibitory activity of membrane tyrosine phosphatases
would not be segregated from the receptors, and CLR signalling
would be attenuated. As mentioned above, non-receptor phos-
phatases such as SHP-1 could also dampen CLR signalling and,
depending on ligand afﬁnity, compete with Syk for binding to the
phosphorylated tyrosine.
CLR signalling is also inﬂuenced by the size of the particle
on which the ligand is expressed. Presentation of CLR ligands on
large particles rather than in solution or even on small parti-
cles could promote delayed or “frustrated” phagocytosis, which
results in an enhanced cytokine response (Hernanz-Falcón et al.,
2009; Rosas et al., 2008) (Fig. 1C). Large aggregates of micropar-
ticulate -glucan, known as Curdlan particles, are much more
potent than non-aggregated -glucan microparticules at induc-
ing signalling and inﬂammatory responses via Dectin-1 expressed
on DCs or macrophages (Rosas et al., 2008). The poor ability of
-glucan microparticles to trigger potent IL-6 or TNF production
via Dectin-1 can be reverted by the actin polymerization inhibitor
cytochalasin D, which blocks phagocytosis of the microparticles
and thus promotes inﬂammatory signals (Rosas et al., 2008). Block-
ade of ligand-driven internalization of Dectin-1, either with large
-glucan particles or with inhibitors of actin polymerization or
dynamin, results in sustained MAPK activation (Hernanz-Falcón
et al., 2009), suggesting that endocytosis of the receptor leads to
attenuation of inﬂammatory responses. This attenuation could be
mediated by disassembly of signalling complexes upon receptor
internalization or by improved access of inhibitory factors (e.g.
phosphatases) to the signalling complex. Other Syk-dependent
signals, however, such as ROS production, appear to be regu-
lated differently since they are active upon receptor internalization
(Underhill et al., 2005). Plated ligands probably mimic  this “frus-
trated” phagocytosis, resulting in exaggerated signalling.
Sensing of self and non-self by myeloid CLRs: plasticity of
functional outcomes
We  describe above how the complexity of signalling motifs and
ligand interaction with myeloid CLRs results in distinct functional
outcomes. In this section, we  illustrate how self and non-self ligands
target CLRs. We  present examples of how myeloid CLRs detect self
for homeostasis or promotion of tolerance, whereas detection of
damaged-self contributes to immunity. When detecting non-self,
myeloid CLRs also act as innate receptors that trigger immunity
and inﬂammation. However, in certain circumstances pathogens
exploit the versatility of CLRs for immune evasion.
Sensing non-self to favour immunity and inﬂammation
The immune system has evolved to protect the host from infec-
tion. Charles Janeway hypothesized the existence of pattern recog-
nition receptors (PRRs) as sensors of pathogen-associated molecu-
lar patterns (PAMPs) and inducers of the co-stimulatory capacity of
DCs (Janeway, 1989). The induction of a signalling pathway by these
PRRs leads to innate cell activation, which in turn orchestrates an
appropriate inﬂammatory response and instructs the nature of the
adaptive response. Most pathogen-detecting CLRs are phagocytic
or scavenger-type receptors, and as such contribute to an immune
response but are not primary drivers. The archetypal example of
a myeloid CLR able to initiate immunity is Dectin-1, which recog-
nizes -glucans present in the cell wall of many fungi (Brown, 2006)
(Fig. 2A). The phosphorylated tyrosine in the hemITAM recruits Syk
kinase, which in turn activates the CARD9/Bcl10/Malt-1 module
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Fig. 1. The nature of the ligand can modulate signalling through myeloid CLRs. Signalling myeloid CLRs can potentially trigger activating or inhibitory signals depending
on  their cytoplasmic signalling motifs and the nature of their ligands. (A) Afﬁnity and avidity of the ligand can affect the quantity and duration of signals through the ITAM
domain. Low afﬁnity/avidity ligands induce hypophosphorylation of the ITAM domain in the FcR chain associated with the CLR. The hypophosphorylated ITAM, termed
“inhibitory ITAM”, preferentially binds SH2-containing protein tyrosine phosphatases (PTPs). Upon binding of a high avidity ligand, the FcR chain ITAM becomes fully
phosphorylated and associates with Syk kinase, which triggers an activating signal. (B) Soluble and particulate ligands are differentially sensed by CLRs. Soluble ligands for
CLR  are poor triggers of activating signalling because of the inhibitory activity of membrane PTPs. When a phagocytic synapse is formed following binding of particulate
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r partic
t
N
(
(
t
Sigands, these phosphatases are segregated from the receptors. (C) CLR signalling 
esulting in attenuation of signalling. Delayed or “frustrated” phagocytosis of large 
hat activates the IB kinase (IKK) complex to induce canonical
F-B signalling (Gross et al., 2006). Syk can also activate MAPK
Leibundgut-Landmann et al., 2007; Slack et al., 2007) and NFAT
Goodridge et al., 2007), which collaborate with NF-B in the activa-
ion of a transcriptional programme. Human Dectin-1 also induces a
yk-independent pathway mediated by the serine/threonineenced by the size of the ligand-bearing particle. Small particles are endocytosed,
les enhances signalling and inﬂammatory responses.
protein kinase Raf-1, which results in acetylation of NF-B and
subsequent modulation of transcription (Gringhuis et al., 2009b).
Activation of these signalling pathways induces transcription of
genes encoding proinﬂammatory cytokines such as TNF, IL-6 and
IL-23 and the regulatory cytokines IL-2 and IL-10 (Leibundgut-
Landmann et al., 2007), a pattern somewhat different from the
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Fig. 2. Self and non-self sensing by myeloid CLRs: plasticity of functional outcomes. The complexity of signalling motifs and ligand interaction with myeloid CLRs can result
in  distinct functional outcomes: (A) Sensing non-self to favour immunity and inﬂammation: Dectin-1 detects -glucan carbohydrates on Candida albicans. After ligand
binding, Dectin-1 can mediate multiple cellular responses in a Syk-dependent or independent (Raf1) manner, including cytokine and chemokine production, respiratory
burst,  phagocytosis and IFN- production. (B) Sensing altered self to foster generation of immunity: Cells infected with cytophatic viruses (HSV-1 or VACV) can be detected
by  TLRs and DNGR-1 expressed on DCs. Whereas PRRs promote activation of the DCs, DNGR-1 favours CTL priming by sequestering cargo in a poorly degradative early
endocytic compartment that allows MHC  class I cross-presentation. (C) Sensing self for homeostasis or promotion of tolerance; Monosodium urate (MSU) is a damage-
associated molecular pattern (DAMP) that induces Syk-dependent ROS production. Clec12a can sense MSU and promote an inhibitory signal through its ITIM that dampens
i ation
m an ma
c
l
a
L
b
tnﬂammation. (D) Sensing non-self to support immune evasion or dampen inﬂamm
acrophages and trigger Syk-coupled secretion of IL-1. SIGNR3 (DC-SIGN in hum
ytokines stimulated by TLRs. The speciﬁc Dectin-1 agonist Curd-
an acts as an adjuvant to trigger an adaptive response in vitro
nd in vivo, leading to Th1 and Th17 type immunity (Leibundgut-
andmann et al., 2007). In addition, sensing of Candida albicans
y Dectin-1 and Dectin-2 results in activation of IFN- produc-
ion through a Syk-IRF5 axis (del Fresno et al., 2013). Dectin-2 is: During Leishmania infantum infection, Dectin-1 and MR induce ROS production in
crophages) promotes parasite survival by inhibiting the LTB4/IL-1 axis.
the predominant Syk-coupled receptor in the response of DCs to
C. albicans, and induction of Th17 immunity against the fungus
in mouse models (Robinson et al., 2009; Saijo et al., 2010). Apart
from inducing transcriptional responses, both Dectin-1 and Dectin-
2 mediate Syk-dependent ROS generation (Gross et al., 2006; Ritter
et al., 2010; Underhill et al., 2005) which has a direct microbicidal
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ole and triggers the NLRP3 inﬂammasome, leading to caspase-1
ctivation and processing of pro-IL-1 to IL-1 essential for anti-
ungal immunity (Gross et al., 2009).
Sensing non-self to induce immunity and inﬂammation confers
he host with an advantage in the ﬁght against a pathogen, but
s an undesired outcome when the non-self triggering agent is an
llergen. Allergenic extracts from Aspergillus fumigatus or house-
ust mites bind Dectin-2 and trigger Syk-dependent arachidonic
cid metabolism and rapid production of cysteinyl leukotrienes
Barrett et al., 2009). These lipid mediators promote Th2 responses
ith increased eosinophilia and neutrophilia in the lung (Barrett
t al., 2011). Another setting in which sensing non-self to pro-
ote inﬂammation can be deleterious to the host is during viral
nfections with severe immunopathology, for example sensing of
engue virus by MDL-1 (CLEC5A), which results in phosphorylation
f DAP12 ITAM and generation of a Syk-dependent proinﬂam-
atory response (Chen et al., 2008). Exaggerated inﬂammation
esults in a shock syndrome, with plasma leakage and subcutaneous
nd vital organ haemorrhaging. Blockade of the MDL-1-Dengue
irus interaction in a mouse model suppresses the secretion of pro-
nﬂammatory cytokines by macrophages, preventing the excessive
mmunopathology (Chen et al., 2008).
ensing self to foster generation of immunity
In addition to directly sensing pathogens, the immune system
lso responds to danger, as demonstrated by adaptive immune
esponses to damaged tissue or necrotic cells in apparently
nfection-free situations. The model of innate recognition of
angerous-self proposes that preformed endogenous adjuvants
nside healthy cells, known as damage-associated molecular
atterns (DAMPs), are exposed or released upon necrotic cell
eath (Matzinger, 1994). The sensing of damaged cells by DCs has
ttracted much interest in understanding how these pathways
ight be exploited to improve vaccine design. The CLR DNGR-1
CLEC9A) is selectively expressed on DC subsets specialized in
ross-presentation of antigens from dead cells in mice and humans
Caminschi et al., 2008; Huysamen et al., 2008; Poulin et al., 2010;
ancho et al., 2008). DNGR-1 recognizes F-actin complexed to the
ctin-binding domain of certain cytoskeletal molecules (Ahrens
t al., 2012; Zhang et al., 2012). To date, no other ligands for
NGR-1 have been found in pathogens, although it has been found
o bind fungal F-actin (Ahrens et al., 2012). It could be argued that
NGR-1 is non-essential for immunity to pathogens. However, our
ork demonstrated that cells infected with vaccinia virus (VACV)
ventually expose DNGR-1 ligands (Iborra et al., 2012) (Fig. 2B);
hile dispensable for activation of DCs, DNGR-1 was crucial for
ross-presentation of necrotic cargo associated with VACV or
erpes simplex virus-type 1 (HSV-1) infected cells (Iborra et al.,
012; Zelenay et al., 2012). DNGR-1 thus plays a non-redundant
ole in the cross-priming of CTLs in models of cytopathic infection
ith HSV-1 or VACV (Iborra et al., 2012; Zelenay et al., 2012). These
esults suggest that DNGR-1 diverts necrotic cargo away from
ysosomes, targeting them for accumulation in a pre-lysosomal
ompartment devoted to cross-presentation (Iborra et al., 2012;
elenay et al., 2012). Sensing of damaged self during viral infection
y DNGR-1 favours antigen processing for cross-presentation and
ooperates with PRRs that mediate activation of DCs to promote CTL
mmunity. Moreover, poxviruses and other intracellular pathogens
re propelled beneath the plasma membrane into surrounding
ells by growing actin tails (Welch and Way, 2013) that are brightly
tained with the DNGR-1 extracellular domain (Ahrens et al., 2012).
ince these actin tails containing DNGR-1 ligand are exposed on
amaged infected cells, one could hypothesize that DNGR-1 has
volved during host-intracellular pathogen co-evolution to detect
his danger signal on infected cells and favour host responses. Thislogy 220 (2015) 175–184 181
interaction would allow non-infected healthy DCs  to take up and
process antigens that can then cross-prime CTL responses.
Sensing self for homeostasis or promotion of tolerance
In addition to the inﬂammation and immunity that can result
from sensing of dangerous-self, self-sensing could also potentially
lead to tolerance or prevention of immunopathology. It has been
proposed the existence of “self-associated molecular patterns”
(SAMPs), which would be recognized by intrinsic cognate inhibitory
receptors self-PRRs (SPRRs) in order to maintain the homeostatic
non-activated state of innate immune cells and dampen their reac-
tivity (Elward and Gasque, 2003; Varki, 2011). An example of
these putative SAMPs is provided by sialic acid patterns, which are
detected by SPRRs such as Siglecs (sialic acid recognizing Ig-like
lectins). These SPRRs often have ITIM motifs within their cytosolic
tails. Consistent with this idea, deletion of Siglec-F from mouse
eosinophils produces a hyperactive response (Zhang et al., 2007),
and mouse Siglec-G deletion results in over-reactive responses to
DAMPs and PAMPs (Chen et al., 2009).
One putative SPRR among CLRs is DCIR. This receptor is
expressed mainly on DCs and has an extracellular carbohydrate
recognition domain and an ITIM motif. Autoimmune-related genes
map  to the DCIR locus in humans, and aged DCIR-deﬁcient mice
spontaneously develop sialadenitis and enthesitis associated with
elevated serum autoantibodies. These mice also showed a markedly
exacerbated response to collagen-induced arthritis. Thus, DCIR
behaves as a SPRR, recognizing a self-associated pattern and
maintaining immune system homeostasis (Fujikado et al., 2008).
Notably, DCIR can be targeted by intravenous immunoglobulins
expressing sialic acid and mediates a negative signal in DCs via SHP-
2 and SHIP-1, resulting in the generation of Tregs and attenuation
of allergic airway disease (Massoud et al., 2014).
Clec12a was recently identiﬁed as another CLR that mediates
an anti-inﬂammatory response through recognizing a well-
established DAMP, uric acid (Neumann et al., 2014) (Fig. 2C).
Uric acid is soluble in healthy cells, but forms monosodium
urate (MSU) crystals when it comes into contact with extracel-
lular sodium ions upon cell death. MSU  activates Syk signalling
in myeloid cells through direct interaction with the membrane
or through unidentiﬁed mechanisms involving CD16 and CD11b
(Barabe et al., 1998; Desaulniers et al., 2001; Ng et al., 2008).
Human and mouse Clec12a both sense MSU  (Neumann et al.,
2014), although it is not fully understood how this recognition
works. MSU  induces Syk-dependent production of reactive oxygen
species (ROS), and Clec12a inhibits this production in neutrophils
(Neumann et al., 2014). Injection of MSU  crystals into the peri-
toneum of mice induces neutrophil inﬁltration that is augmented
in Clec12a-deﬁcient mice. Notably, Clec12a does not affect ROS
production induced by Dectin-1, suggesting that, to induce its
inhibitory effects, Clec12a requires co-engagement with the acti-
vating receptor for MSU. Because Clec12a includes an ITIM within
its cytoplasmic tail, its negative regulatory role is likely to be medi-
ated by recruited phosphatases.
Sensing non-self to support immune evasion or dampen
inﬂammation
The proposal that SAMPs dampen inﬂammation in response
to self antigens opens up a possible route for pathogens to
mimic  SAMPs for their own  beneﬁt. For example, the Trypanosoma
cruzi cell surface contains sialoglycoproteins and sialyl-binding
proteins that assist the parasite in several functions including
parasite survival, infectivity, and host–cell recognition, and could
act as SAMPs (Freire-de-Lima et al., 2012). ITIM-coupled CLRs
such as DCIR could behave as SPRRs that are targeted directly or
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ndirectly (e.g. by tissue damage) by pathogens to dampen
mmunity and inﬂammation. In this regard, DCIR-deﬁcient mice
Clec4a2−/−) exhibit severe inﬂammatory disease upon Chikun-
unya virus infection (Long et al., 2013). Early differences in
irus-induced disease between DCIR-deﬁcient and wild-type mice
re independent of viral replication, and there is no evidence for
irect interactions between DCIR and Chikungunya virus, suggest-
ng that DCIR might sense the pathogen indirectly and contribute
o increased tolerance of pathogen-induced damage by dampen-
ng immunopathology and reducing the negative impact of the
athogen on host ﬁtness (Medzhitov et al., 2012). Conversely, in
 model of cerebral malaria caused by Plasmodium berghei, DCIR-
eﬁcient mice are more resistant, correlating with reduced T-cell
riming in the spleen, decreased TNF levels in the serum, and
iminished T-cell retention in the brain (Maglinao et al., 2013). No
vidence was found for direct binding of DCIR to P. berghei, suggest-
ng that DCIR recognizes a self-DAMP released by the rupture of red
lood cells during infection. These studies highlight the potential
lasticity of DCIR depending on the ligand and the inﬂammatory
ontext.
As discussed above, inhibitory signals can also be mediated by
TAM-coupled receptors. The ITAM-coupled CLR Mincle, in addi-
ion to sensing SAP-130 – a self-ligand released by necrotic cells
Yamasaki et al., 2008) – binds glycolipids in the cell walls of
ungi and bacteria (Ishikawa et al., 2009, 2013; Schoenen et al.,
010; Sousa et al., 2011; Yamasaki et al., 2009). Mincle is an
ctivating receptor that upon ligand recognition triggers a strong
yk-dependent inﬂammatory response and robust Th1 and Th17
mmunity (Ishikawa et al., 2009, 2013; Schoenen et al., 2010;
henderov et al., 2013; Sousa et al., 2011; Wells et al., 2008;
amasaki et al., 2009). However, in certain conditions Mincle can
eliver a negative signal to heterologous receptors. Mincle and
ectin-1 recognize Fonsecaea monophora, a cause of chromoblasto-
ycosis. Stimulation of human DCs with F. monophora triggers the
aturation of DCs and production of IL-6, IL-1 and IL-23, but not
L-12p70. While Dectin-1 acts as a PRR, promoting Syk-dependent
ytokine production, stimulation of Syk by Mincle triggers a PKB-
ependent signal that leads to loss of IRF1 activity (Wevers et al.,
014). Notably, Mincle suppresses TLR-4-induced IL-12p70 expres-
ion by inhibiting IL-12p35 transcription (Wevers et al., 2014).
hese ﬁndings suggest that Mincle can support or inhibit immu-
ity depending on the nature of the ligand, thus modulating the
esponse of heterologous receptors for the same pathogen. Min-
le is also involved in innate sensing of F. pedrosoi in mice, but
his recognition does not seem to be efﬁcient enough to promote
rotective immunity against the fungus, instead leading to chronic
nfection (Sousa et al., 2011). Intriguingly, when mice are treated
ith TLR agonists, TLR signalling cooperates with Mincle in the
eneration of a potent inﬂammatory response that resolves the dis-
ase (Sousa et al., 2011). The reasons for this apparent discrepancy
etween humans and mice are unknown, but it could imply the
xistence of additional receptors that heterodimerize with Min-
le in mouse, as described for MCL  (Miyake et al., 2013), or of
ifferent transduction modules associated with human monocyte-
erived DCs compared with mouse bone marrow-derived DCs. In
his regard, the ability of a given CLR to drive NF-B activation is
yeloid-cell-type dependent. DCs derived from bone marrow pro-
enitors and differentiated in vitro with GM-CSF are easily activated
y Dectin-1 agonists, whereas Flt3L-derived bone marrow DCs and
-CSF-derived macrophages are poor NF-B activators (Goodridge
t al., 2009). This difference might be explained by the expres-
ion levels of CARD9 or other key limiting signalling proteins. Thus,
epending on the cellular context, the simultaneous engagement
f CLRs and TLRs could lead to cooperation or antagonism.
DC-SIGN recognizes endogenous glycoproteins and also inter-
cts with a wide range of pathogens through the recognition oflogy 220 (2015) 175–184
mannose and fucose, but its contribution to host defence is still
debated. DC-SIGN can contribute to adaptive immunity by targeting
antigens to late endosomal/lysosomal compartments for degrada-
tion and presentation to T cells. But DC-SIGN also induces signals
that promote HIV-1 replication in DCs and transmission to T cells
(Hodges et al., 2007; Kwon et al., 2002). Similarly, the interaction
of M.  tuberculosis with DC-SIGN suggests that the pathogen has
evolved to exploit the receptor as part of an immunoevasive strat-
egy involving the secretion of the immunosuppressive cytokine
IL-10 from DCs (Geijtenbeek et al., 2003). Mannose-containing M.
tuberculosis and HIV-1 induce the recruitment of the LSP1 signalo-
some described above, which activates Raf-1 and modulates TLR
signalling (Gringhuis et al., 2007, 2009a). The DCs  of transgenic mice
expressing human DC-SIGN under the control of the mouse CD11c
promoter (termed hSIGN) produce signiﬁcantly less IL-12p40 than
wild-type counterparts and similar amounts of IL-10. After infec-
tion with M. tuberculosis, hSIGN mice show massive accumulation
of DC-SIGN+ cells in infected lungs, below-normal tissue damage
and prolonged survival. These results suggest that, rather than pro-
moting immune evasion by mycobacteria, human DC-SIGN may
have evolved to limit tuberculosis-induced pathology (Schaefer
et al., 2008). Similarly, the DC-SIGN mouse homolog SIGNR3 damp-
ens inﬂammation mediated by other CLRs that sense Leishmania
infection (Lefèvre et al., 2013) (Fig. 2D). Macrophages act as the
main host and primary effector cells during Leishmania infection.
The macrophage response to Leishmania infantum in vivo is charac-
terized by M2b  polarization (Mantovani et al., 2004) and is detected
by Dectin-1, mannose receptor (MR), and SIGNR3. Dectin-1 and MR
respectively activate Syk-p47phox and arachidonic acid-NADPH
oxidase signalling pathways, both of which are needed for ROS
production, and also trigger Syk-coupled signalling for caspase-
1-induced IL-1 secretion. Dectin-1 and MR thus contribute to
parasite containment, whereas SIGNR3 favours parasite resilience
through inhibition of the LTB4-IL-1  axis.
Concluding remarks
Myeloid CLRs detect self and non-self to mediate multiple
roles. The outcome of myeloid CLR interaction with a ligand
depends critically on the signals triggered, which are conditioned
by the signalling motifs. The classical view of activating ITAMs and
inhibitory ITIMs is complicated by the ability of low ligand density
to lead to inhibitory ITAM signalling. Additionally, under certain
circumstances Syk-dependent responses can also lead to inhibi-
tion of gene transcription. Soluble ligands also result in weaker
signalling than particulate ligands, which form a synapse that
excludes inhibitory phosphatases. In addition, large particles that
frustrate phagocytosis can signal for longer than small particles,
whose signal is attenuated by endocytosis.
This complex and versatile regulation of functional responses
depends on the ligand and the signalling motifs present in the
receptor and leads to a great variety of responses to self and
non-self antigens. Myeloid CLRs mediate immunity and inﬂam-
mation against non-self, in collaboration with the detection of
dangerous-self signals. However, CLRs can also be targeted by
pathogens and self ligands to dampen inﬂammation and immunity.
These functions might have been selected in evolution to reduce
immunopathology by increasing host tolerance of pathogen-
induced damage, providing an alternative strategy to reducing the
negative impact of the pathogen on host ﬁtness. Further research is
needed to clarify the contribution of ligands and signalling motifs
to the functional outcomes of signalling through myeloid CLRs,
with the aim of identifying novel targets for improving immunity
against pathogen or, conversely, reducing the immunopathology
associated with infection.
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